Patents by Inventor Scott Chouinard
Scott Chouinard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240173013Abstract: An effective blood vessel diameter at a deployment site within a blood vessel may be determined using a measurement apparatus that includes an inflatable balloon. The measurement apparatus may be advanced to the deployment site and the inflatable balloon may be inflated in order to temporarily reshape the blood vessel at the deployment site to a more circular cross-sectional profile. A measurement pertaining to the effective vessel diameter may be obtained while the inflatable balloon remains inflated. The measurement may be obtained using an ultrasound catheter. The measurement may be obtained using fluoroscopy, for example.Type: ApplicationFiled: November 28, 2023Publication date: May 30, 2024Applicant: Boston Scientific Scimed, Inc.Inventors: Ewnet Gebrehiwot, Paul F. Chouinard, Brady Scott Logan
-
Publication number: 20240172960Abstract: An effective vessel diameter of a blood vessel at a deployment site may be determined using a measurement apparatus that includes an expandable element that is moveable between a collapsed configuration for advancement and an expanded configuration for measurement. The measurement apparatus may be advanced to the deployment site with the expandable element in its collapsed configuration. The expandable element may be caused to expand from its collapsed configuration to its expanded configuration and one or more measurements pertaining to the expandable element in its expanded configuration may be obtained. The one or more measurements may be used to determine an effective vessel diameter at the deployment site.Type: ApplicationFiled: November 28, 2023Publication date: May 30, 2024Applicant: Boston Scientific Scimed, Inc.Inventors: Paul F. Chouinard, Brady Scott Logan, Ewnet Gebrehiwot
-
Publication number: 20240065864Abstract: An endoprosthesis for preventing collapse of a vein may include an expandable framework configured to shift between a radially collapsed configuration and a radially expanded configuration, and a plurality of anchoring legs extending axially away from a first end of the expandable framework. The plurality of anchoring legs may be configured to shift between a delivery configuration and a deployed configuration. In the deployed configuration, the plurality of anchoring legs may be configured to extend radially outward of the expandable framework in the radially expanded configuration. A system for preventing collapse of a vein may include a delivery catheter having a lumen, an endoprosthesis disposable within a distal portion of the lumen in a radially collapsed configuration, and at least one filament coupled to the plurality of anchor legs of the endoprosthesis and extending within the lumen of the delivery catheter.Type: ApplicationFiled: August 28, 2023Publication date: February 29, 2024Applicant: BOSTON SCIENTIFIC SCIMED, INC.Inventors: Brady Scott Logan, Paul F. Chouinard
-
Patent number: 9005981Abstract: The present invention is in the field of identification and characterization of novel insecticidal target sites and, in particular, relates to host cells, assays and antibodies thereto.Type: GrantFiled: December 22, 2009Date of Patent: April 14, 2015Assignee: Dow AgroSciences LLCInventors: Nailah Orr, Gerald B. Watson, Gary D. Gustafson, James M. Hasler, Chaoxian Geng, Scott Chouinard, Kevin R. Cook, Vincent L. Salgado
-
Publication number: 20120028822Abstract: A method, flow cell and/or device for increasing the recovery of a limiting analyte in a sample, e.g., for single molecule analysis is disclosed. Methods for preparing a nucleic acid sample from a single cell and capturing nucleic acids on a surface configured for use in or with single molecule analysis are also provided.Type: ApplicationFiled: November 4, 2009Publication date: February 2, 2012Applicant: HELICOS BIOSCIENCES CORPORATIONInventors: Richard Joseph, James Dimeo, Mirna Jarosz, John F. Thompson, Jayson Bowers, Scott Chouinard, Philipp Kapranov, William J. Efcavitch, Christopher Hart, Fatih Ozsolak
-
Publication number: 20100233696Abstract: A method, flow cell and/or device for increasing the recovery of a limiting analyte in a sample, e.g., for single molecule analysis is disclosed. Methods for preparing a nucleic acid sample from a single cell and capturing nucleic acids on a surface configured for use in or with single molecule analysis are also provided.Type: ApplicationFiled: November 4, 2009Publication date: September 16, 2010Applicant: HELICOS BIOSCIENCES CORPORATIONInventors: Richard Joseph, James J. DiMeo, Mirna Jarosz, John F. Thompson, Jayson Bowers, Scott Chouinard, Philipp Kapronov, J. William Efcavitch, Christopher Hart, Fatih Ozsolak
-
Publication number: 20100212029Abstract: The present invention is in the field of identification and characterization of novel insecticidal target sites and, in particular, relates to host cells, assays and antibodies thereto.Type: ApplicationFiled: December 22, 2009Publication date: August 19, 2010Applicant: DOW AGROSCIENCES LLCInventors: Nailah Orr, Gerald B. Watson, Gary D. Gustafson, James M. Hasler, Chaoxian Geng, Scott Chouinard, Kevin R. Cook, Vincent L. Salgado
-
Publication number: 20060269995Abstract: The present invention is in the field of identification and characterization of novel insecticidal target sites and, in particular, relates to host cells, assays and antibodies thereto.Type: ApplicationFiled: February 23, 2006Publication date: November 30, 2006Inventors: Nailah Orr, Gerald Watson, Gary Gustafson, James Hasler, Chaoxian Geng, Kevin Cook, Vincent Salgado, Scott Chouinard
-
Patent number: 6846482Abstract: The invention includes an expression vector engineered to produce double-stranded RNA (dsRNA) within a pest to be controlled. The dsRNA inhibits expression of at least one gene within the pest, wherein inhibition of the gene exerts a deleterious effect upon the pest. For example, inhibition of the gene can lead to cessation of feeding, growth, or development and can cause death of the pest. In a preferred embodiment of the invention the expression vector is a recombinant baculovirus that transcribes sense and antisense RNA under the control of the baculovirus IE-1 promoter and hr5 enhancer. Preferred genes to be inhibited include essential genes, genes involved in neurotransmission, and genes that are targets for conventional pesticides. The invention discloses baculovirus transfer plasmids useful for producing the recombinant baculovirus. The invention further discloses methods and formulations involving the expression vector.Type: GrantFiled: August 13, 2001Date of Patent: January 25, 2005Assignee: Cambria BiosciencesInventors: Leo Liu, Scott Chouinard, James Velema
-
Publication number: 20020137710Abstract: The invention includes an expression vector engineered to produce double-stranded RNA (dsRNA) within a pest to be controlled. The dsRNA inhibits expression of at least one gene within the pest, wherein inhibition of the gene exerts a deleterious effect upon the pest. For example, inhibition of the gene can lead to cessation of feeding, growth, or development and can cause death of the pest. In a preferred embodiment of the invention the expression vector is a recombinant baculovirus that transcribes sense and antisense RNA under the control of the baculovirus IE-1 promoter and hr5 enhancer. Preferred genes to be inhibited include essential genes, genes involved in neurotransmission, and genes that are targets for conventional pesticides. The invention discloses baculovirus transfer plasmids useful for producing the recombinant baculovirus. The invention further discloses methods and formulations involving the expression vector.Type: ApplicationFiled: August 13, 2001Publication date: September 26, 2002Inventors: Leo Liu, Scott Chouinard, James Velema
-
Patent number: 6326193Abstract: The invention includes an expression vector engineered to produce double-stranded RNA (dsRNA) within a pest to be controlled. The dsRNA inhibits expression of at least one gene within the pest, wherein inhibition of the gene exerts a deleterious effect upon the pest. For example, inhibition of the gene can lead to cessation of feeding, growth, or development and can cause death of the pest. In a preferred embodiment of the invention the expression vector is a recombinant baculovirus that transcribes sense and antisense RNA under the control of the baculovirus IE-1 promoter and hr5 enhancer. Preferred genes to be inhibited include essential genes, genes involved in neurotransmission, and genes that are targets for conventional pesticides. The invention discloses baculovirus transfer plasmids useful for producing the recombinant baculovirus. The invention further discloses methods and formulations involving the expression vector.Type: GrantFiled: November 24, 1999Date of Patent: December 4, 2001Assignee: Cambria Biosciences, LLCInventors: Leo Liu, Scott Chouinard, James Velema